BioSpace News Archive

The world’s first whole-body portable ultrasound continues its rapid global expansion and distribution, while demonstrating significant clinical utility in fighting the COVID-19 pandemic

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the following statement amid the continued COVID-19 global crisis, severely impacting public health and the economy.

CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) announces that it has reached a preliminary agreement, which became effective on March 26, 2020 following the consent of the two main creditors of Terranueva, with the owners of the pharmaceutical company LSL Laboratory Inc. (“LSL Laboratory”) for the acquisition of all of LSL Laboratory’s outstanding securities issued by the company (the “Shares”).

New York-based Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a first-of-its-kind microchannel drug delivery technology, today announces that the company has filed two patent applications with the United States Patent and Trademark Office.

EPAM Systems, Inc. (NYSE: EPAM), a leading global provider of digital platform engineering and software development services, today announced that it has released the GENTL Mask, an open source solution for manufacturers to address the supply shortage of protective masks that medical professionals need amid the coronavirus outbreak

Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into definitive agreements with several institutional investors for the purchase and sale of 873,332 shares of Astrotech’s common stock, at a purchase price of $3.75 per share, in a registered direct offering priced at-the-market under Nasdaq rules

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today confirmed that its products are now fully compliant – with the updated regulations and standards established by the Florida Department of Agriculture and Consumer Services (“State of Florida” or “Florida”).

Transplant centers and organ procurement organizations are working through this unprecedented event to continue to recover donated organs and perform transplants.

Health products that make false and misleading claims to prevent, treat or cure COVID-19.

The ATA, the premier organization working to accelerate the adoption of telehealth, commended Congress for passing the bipartisan Coronavirus Aid, Relief, and Economic Security Act, the third bipartisan package to support Americans in the fight against the COVID-19 pandemic.